[Two cases of ataxic sensory neuropathy associated with silicosis].
Two patients of ataxic sensory neuropathy associated with silicosis were studied. Case 1 is a 53-year-old (in 1979) man who was a stonecutter for 40 years and diagnosed as silicosis in 1973. Case 2 is a 64-year-old (in 1984) man who was a glasscutter for 30 years and had been treated for silicosis from 1980 to 1982. Both patients developed dysesthesias in the hands, feet and face asymmetrically and gait ataxia over a few months. Vibratory and joint position senses were profoundly diminished but were accompanied by only mildly decreased pain and temperature sensations. Their muscle power was almost unchanged. Both had absent muscle power was almost unchanged. Both had absent muscle stretch reflexes. Sensory nerve conduction velocities were absent and motor nerve studies were almost normal. Nerve biopsy in case 2 showed a severe loss of large myelinaed fibers, and no inflammatory infiltrates and onion bulb formations. Although these findings suggested the carcinomatous neuropathy, we could not find any malignancy. Both patients had elevated polyclonal gamma-globulin levels and rheumatoid factors and, in case 2 an increase of IgG in serum. Cerebrospinal fluid showed an albumino-cytogenic dissociation and steroid therapy was successful in both patients. Case 1 died of pneumonia in 1989. Though an autopsy was not performed, his condition had continued to improve without signs of malignancy during 10 years. The condition of case 2 has also continued to improve, although ataxias remain.(ABSTRACT TRUNCATED AT 250 WORDS)
Tokumaru
Y
Y
Department of Neurology, School of Medicine, Chiba University.
Hirayama
K
K
Kita
K
K
Kawamura
M
M
Katayama
K
K
D001259:Ataxia / Q000188:drug therapy / Q000209:etiology*; D015551:Autoimmunity; D006801:Humans; D008297:Male; D008875:Middle Aged; D009475:Neurons, Afferent; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy / Q000209:etiology*; D011115:Polyneuropathies / Q000188:drug therapy / Q000209:etiology*; D011239:Prednisolone / Q000008:administration & dosage; D012829:Silicosis / Q000150:complications* / Q000276:immunology
D011239:Prednisolone